Tabula Rasa HealthCare, Inc. revised preliminary revenue guidance for the fourth quarter 2022 . Revenue from continuing operations for the fourth quarter of 2022 is expected to be between $82 $83 million, exceeding the prior guidance range of $77.5 $80.5 million.
Tabula Rasa HealthCare, Inc.
Equities
TRHC
US8733791011
Advanced Medical Equipment & Technology
1st Jan change | Capi. | |
---|---|---|
-2.39% | 30.38B | |
+37.51% | 9.35B | |
+35.03% | 4.45B | |
-40.39% | 2.26B | |
-6.10% | 1.66B | |
-29.44% | 1.22B | |
-41.27% | 1.01B | |
-6.21% | 840M | |
-49.31% | 707M |